Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | SNCA | P37840 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.38 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.38 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2108457 | 1.00 | TRPA1 (0.46) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL2108465 | 1.00 | TRPA1 (0.46) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL2853775 | 1.00 | TRPA1 (0.46) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL7139094 | 0.91 | MAOB (0.42) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL7139096 | 0.91 | MAOB (0.42) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL28354139 | 0.88 | TRPA1 (0.44) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL7170869 | 0.88 | TRPA1 (0.44) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL29358897 | 0.88 | TRPA1 (0.44) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL204249 | 0.88 | TRPA1 (0.44) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL7170865 | 0.88 | TRPA1 (0.44) | TRPA1NFE2L2CYP1A2CYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041028-A1 | DELIVERY SYSTEM FOR PLANT PROTECTION | OMYA INTERNATIONAL AG (CH) | 2024-02-08 | — | — | US | disclosed |
| US-11882834-B2 | Microbiocidal thiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2024-01-30 | — | — | US | disclosed |
| EP-4271185-A1 | DELIVERY SYSTEM FOR PLANT PROTECTION | Omya International AG (CH) | 2023-11-08 | — | — | EP | disclosed |
| EP-3244732-B1 | USE OF SURFACE-REACTED CALCIUM CARBONATE AS CARRIER FOR AGROCHEMICAL COMPOUNDS | OMYA INT AG (CH) | 2023-05-03 | — | — | EP | disclosed |
| US-11566140-B2 | Exterior coating composition | TROY CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-11535594-B2 | Microbiocidal picolinamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2022-12-27 | — | — | US | disclosed |
| WO-2022144403-A1 | DELIVERY SYSTEM FOR PLANT PROTECTION | OMYA INTERNATIONAL AG (CH) | 2022-07-07 | — | — | WO | disclosed |
| US-11192867-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-12-07 | — | — | US | disclosed |
| US-11154060-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-26 | — | — | US | disclosed |
| US-11066375-B2 | Microbiocidal oxadiazole derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-20 | — | — | US | disclosed |
| US-20160355518-A1 | MICROBIOCIDAL HETEROBICYCLIC DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-12-08 | — | — | US | disclosed |
| WO-2016113289-A1 | USE OF SURFACE-REACTED CALCIUM CARBONATE AS CARRIER FOR AGROCHEMICAL COMPOUNDS | OMYA INTERNATIONAL AG (CH) | 2016-07-21 | — | — | WO | disclosed |
| EP-3045042-A1 | USE OF SURFACE-REACTED CALCIUM CARBONATE AS CARRIER FOR AGROCHEMICAL COMPOUNDS | Omya International AG (CH) | 2016-07-20 | — | — | EP | disclosed |
| US-8314146-B2 | Thioamide compounds, method of making and method of using thereof | MERIAL LIMITED (US) | 2012-11-20 | — | — | US | disclosed |
| US-8283475-B2 | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof | MERIAL LIMITED (US) | 2012-10-09 | — | — | US | disclosed |
| US-20120149750-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | MERIAL, INC. | 2012-06-14 | — | — | US | disclosed |
| US-20080312272-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | MERIAL, INC. | 2008-12-18 | — | — | US | disclosed |
| US-6846777-B2 | Synergistic biocidal composition | THOR GMBH (DE) | 2005-01-25 | — | — | US | disclosed |
| US-20030199490-A1 | Synergistic biocidal composition | THOR GMBH (DE) | 2003-10-23 | — | — | US | disclosed |
| US-5466693-A | FOE USE IN THE CULTIVATION OF RICE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11882834-B2 | Microbiocidal thiazole derivatives | MSR1, TLR1, IFNG | TRPA1 45/4885NFE2L2 1250/4885CYP1A2 352/4885 |
| US-20120149750-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | CYP4X1, CBR3, TYR | TRPA1 2917/4885NFE2L2 2461/4885CYP1A2 23/4885 |
| US-20080312272-A1 | ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF | CYP4X1, CBR3, TYR | TRPA1 2917/4885NFE2L2 2461/4885CYP1A2 23/4885 |
| US-11192867-B2 | Microbiocidal oxadiazole derivatives | PRF1, NOX1, ARG2 | TRPA1 291/4885NFE2L2 1600/4885CYP1A2 172/4885 |
| US-11066375-B2 | Microbiocidal oxadiazole derivatives | PRF1, NOX1, ARG1 | TRPA1 305/4885NFE2L2 1816/4885CYP1A2 107/4885 |
| US-20160355518-A1 | MICROBIOCIDAL HETEROBICYCLIC DERIVATIVES | MSR1, C1R, C3AR1 | TRPA1 1720/4885NFE2L2 3757/4885CYP1A2 415/4885 |
| US-11535594-B2 | Microbiocidal picolinamide derivatives | PRF1, CASP1, FPR1 | TRPA1 6/4885NFE2L2 1817/4885CYP1A2 305/4885 |
| US-11154060-B2 | Microbiocidal oxadiazole derivatives | MPO, MSR1, NOX3 | TRPA1 536/4885NFE2L2 2372/4885CYP1A2 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.